Cobimetinib in Pediatric and Young Adult Patients with Relapsed or Refractory Solid Tumors (iMATRIX-cobi): A Multicenter, Phase I/II Study.
- Resource Type
- Article
- Source
- Targeted Oncology; May2022, Vol. 17 Issue 3, p283-293, 11p
- Subject
- Language
- ISSN
- 17762596